Co-Authors
This is a "connection" page, showing publications co-authored by Abhilash Perisetti and Hemant Goyal.
Connection Strength
9.172
-
Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic. Dig Dis Sci. 2021 04; 66(4):945-953.
Score: 0.932
-
COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations. Dis Mon. 2020 Sep; 66(9):101064.
Score: 0.895
-
Putative Mechanisms of Diarrhea in COVID-19. Clin Gastroenterol Hepatol. 2020 12; 18(13):3054-3055.
Score: 0.887
-
COVID-19 and gastrointestinal endoscopies: Current insights and emergent strategies. Dig Endosc. 2020 Jul; 32(5):715-722.
Score: 0.885
-
Colorectal cancer screening use among insured adults: Is out-of-pocket cost a barrier to routine screening? World J Gastrointest Pharmacol Ther. 2018 Sep 05; 9(4):31-38.
Score: 0.784
-
Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19. Eur J Gastroenterol Hepatol. 2022 02 01; 34(2):137-141.
Score: 0.248
-
Management of gastrointestinal bleeding during COVID-19: less is more! Eur J Gastroenterol Hepatol. 2021 09 01; 33(9):1230-1232.
Score: 0.241
-
'Scope' of acute esophageal obstruction in the era of COVID-19. Eur J Gastroenterol Hepatol. 2021 09 01; 33(9):1234-1236.
Score: 0.241
-
Gastrointestinal Endoscopy in the Era of COVID-19. Front Med (Lausanne). 2020; 7:587602.
Score: 0.229
-
Percutaneous Endoscopic Gastrostomy tube placement in COVID-19 patients: Multidisciplinary approach. Dig Endosc. 2021 Jan; 33(1):209.
Score: 0.228
-
Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Front Med (Lausanne). 2020; 7:581521.
Score: 0.228
-
The Association of "Loss of Smell" to COVID-19: A Systematic Review and Meta-Analysis. Am J Med Sci. 2021 02; 361(2):216-225.
Score: 0.228
-
Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19. Front Med (Lausanne). 2020; 7:588711.
Score: 0.228
-
Hyperlipasemia and Potential Pancreatic Injury Patterns in COVID-19: A Marker of Severity or Innocent Bystander? Gastroenterology. 2021 02; 160(3):946-948.e2.
Score: 0.228
-
Antibody tests for COVID-19. Proc (Bayl Univ Med Cent). 2020 Oct 13; 34(1):63-72.
Score: 0.227
-
Current and future implications of COVID-19 on gastroenterology training and clinical practice. Int J Clin Pract. 2020 Dec; 74(12):e13717.
Score: 0.227
-
Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned. Ann Gastroenterol. 2020 Nov-Dec; 33(6):591-602.
Score: 0.227
-
Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020; 7:586221.
Score: 0.226
-
Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19. Front Med (Lausanne). 2020; 7:526.
Score: 0.224
-
Racial and Gender-Based Differences in COVID-19. Front Public Health. 2020; 8:418.
Score: 0.224
-
Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020; 7:431.
Score: 0.223
-
Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019. J Clin Exp Hepatol. 2020 Nov-Dec; 10(6):533-539.
Score: 0.222
-
Clinical Insights into the Gastrointestinal Manifestations of COVID-19. Dig Dis Sci. 2020 07; 65(7):1932-1939.
Score: 0.221
-
Taste Changes (Dysgeusia) in COVID-19: A Systematic Review and Meta-analysis. Gastroenterology. 2020 Sep; 159(3):1132-1133.
Score: 0.220
-
Cannabis in liver disorders: a friend or a foe? Eur J Gastroenterol Hepatol. 2018 11; 30(11):1283-1290.
Score: 0.198
-
New and emerging therapies in treatment of Clostridium difficile infection. Eur J Gastroenterol Hepatol. 2018 06; 30(6):589-597.
Score: 0.193
-
Gastrointestinal Symptoms and Outcomes in Hospitalized Coronavirus Disease 2019 Patients. Dig Dis. 2020; 38(5):373-379.
Score: 0.056